Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Research and Development Costs and Returns: The U.S. Pharmaceutical Industry

10 references·5 citing·32 second hop

FromToDepth

this work references cited by second hop

References

1962Economic Welfare and the Allocation of Resources for Invention8,931 cited
1960Is Aggregation Necessarily Bad?424 cited
1970Invention, Growth and Welfare.369 cited
1969Patent Statistics as a Measure of Technical Change346 cited
1956Linear Aggregation of Economic Relations.344 cited
1967Research and Development Resource Allocation Under Rivalry332 cited
1968Optimal Timing of Innovations276 cited
1969The Existence of Aggregate Production Functions257 cited
1960Demand relations with autocorrelated disturbances.166 cited
1965Research and Technical Change in the Pharmaceutical Industry138 cited

Cited by

2004Are the Economics of Pharmaceutical Research and Development Changing?88 cited
2006Is the Pharmaceutical Industry in a Productivity Crisis?77 cited
1995THE VERTICAL CHAIN OF RESEARCH AND DEVELOPMENT IN THE PHARMACEUTICAL INDUSTRY65 cited
1999The Stock Market Valuation of Research and Development Expenditures35 cited
2000Integration problems and turnaround strategies in a cross-border merger A clinical examination of the Pharmacia-Upjohn merger26 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work